Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Jan 15;101(2):503–510. doi: 10.1172/JCI275

Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus.

P B Jensen 1, N Blume 1, J D Mikkelsen 1, P J Larsen 1, H I Jensen 1, J J Holst 1, O D Madsen 1
PMCID: PMC508591  PMID: 9435324

Abstract

We have isolated a stable, transplantable, and small glucagonoma (MSL-G-AN) associated with abrupt onset of severe anorexia occurring 2-3 wk after subcutaneous transplantation. Before onset of anorexia, food consumption is comparable to untreated controls. Anorexia is followed by adipsia and weight loss, and progresses rapidly in severity, eventually resulting in reduction of food and water intake of 100 and 80%, respectively. During the anorectic phase, the rats eventually become hypoglycemic and hypothermic. The tumor-associated anorexia shows no sex difference, and is not affected by bilateral abdominal vagotomy, indicating a direct central effect. The adipose satiety factor leptin, known to suppress food intake by reducing hypothalamic neuropeptide Y (NPY) levels, was not found to be expressed by the tumor, and circulating leptin levels were reduced twofold in the anorectic phase. A highly significant increase in hypothalamic (arcuate nucleus) NPY mRNA levels was found in anorectic rats compared with control animals. Since elevated hypothalamic NPY is among the most potent stimulators of feeding and a characteristic of most animal models of hyperphagia, we conclude that the MSL-G-AN glucagonoma releases circulating factor(s) that overrides the hypothalamic NPY-ergic system, thereby eliminating the orexigenic effect of NPY. We hypothesize a possible central role of proglucagon-derived peptides in the observed anorexia.

Full Text

The Full Text of this article is available as a PDF (237.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe M., Saito M., Ikeda H., Shimazu T. Increased neuropeptide Y content in the arcuato-paraventricular hypothalamic neuronal system in both insulin-dependent and non-insulin-dependent diabetic rats. Brain Res. 1991 Jan 25;539(2):223–227. doi: 10.1016/0006-8993(91)91624-a. [DOI] [PubMed] [Google Scholar]
  2. Akabayashi A., Wahlestedt C., Alexander J. T., Leibowitz S. F. Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion. Brain Res Mol Brain Res. 1994 Jan;21(1-2):55–61. doi: 10.1016/0169-328x(94)90377-8. [DOI] [PubMed] [Google Scholar]
  3. Bai F. L., Yamano M., Shiotani Y., Emson P. C., Smith A. D., Powell J. F., Tohyama M. An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. Brain Res. 1985 Apr 1;331(1):172–175. doi: 10.1016/0006-8993(85)90730-9. [DOI] [PubMed] [Google Scholar]
  4. Beck B., Burlet A., Bazin R., Nicolas J. P., Burlet C. Elevated neuropeptide Y in the arcuate nucleus of young obese Zucker rats may contribute to the development of their overeating. J Nutr. 1993 Jun;123(6):1168–1172. doi: 10.1093/jn/123.6.1168. [DOI] [PubMed] [Google Scholar]
  5. Beck B., Jhanwar-Uniyal M., Burlet A., Chapleur-Chateau M., Leibowitz S. F., Burlet C. Rapid and localized alterations of neuropeptide Y in discrete hypothalamic nuclei with feeding status. Brain Res. 1990 Oct 1;528(2):245–249. doi: 10.1016/0006-8993(90)91664-3. [DOI] [PubMed] [Google Scholar]
  6. Blume N., Skouv J., Larsson L. I., Holst J. J., Madsen O. D. Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis. J Clin Invest. 1995 Nov;96(5):2227–2235. doi: 10.1172/JCI118278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brubaker P. L., Lee Y. C., Drucker D. J. Alterations in proglucagon processing and inhibition of proglucagon gene expression in transgenic mice which contain a chimeric proglucagon-SV40 T antigen gene. J Biol Chem. 1992 Oct 15;267(29):20728–20733. [PubMed] [Google Scholar]
  8. Campfield L. A., Smith F. J., Guisez Y., Devos R., Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 1995 Jul 28;269(5223):546–549. doi: 10.1126/science.7624778. [DOI] [PubMed] [Google Scholar]
  9. Chance W. T., Balasubramaniam A., Sheriff S., Fischer J. E. Possible role of neuropeptide Y in experimental cancer anorexia. Adv Exp Med Biol. 1994;354:185–201. doi: 10.1007/978-1-4899-0939-8_14. [DOI] [PubMed] [Google Scholar]
  10. Chen H., Charlat O., Tartaglia L. A., Woolf E. A., Weng X., Ellis S. J., Lakey N. D., Culpepper J., Moore K. J., Breitbart R. E. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell. 1996 Feb 9;84(3):491–495. doi: 10.1016/s0092-8674(00)81294-5. [DOI] [PubMed] [Google Scholar]
  11. Chua S. C., Jr, Chung W. K., Wu-Peng X. S., Zhang Y., Liu S. M., Tartaglia L., Leibel R. L. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science. 1996 Feb 16;271(5251):994–996. doi: 10.1126/science.271.5251.994. [DOI] [PubMed] [Google Scholar]
  12. Coleman D. L. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia. 1973 Aug;9(4):294–298. doi: 10.1007/BF01221857. [DOI] [PubMed] [Google Scholar]
  13. Davies L., Marks J. L. Role of hypothalamic neuropeptide Y gene expression in body weight regulation. Am J Physiol. 1994 May;266(5 Pt 2):R1687–R1691. doi: 10.1152/ajpregu.1994.266.5.R1687. [DOI] [PubMed] [Google Scholar]
  14. Dryden S., Frankish H., Wang Q., Williams G. Neuropeptide Y and energy balance: one way ahead for the treatment of obesity? Eur J Clin Invest. 1994 May;24(5):293–308. doi: 10.1111/j.1365-2362.1994.tb01089.x. [DOI] [PubMed] [Google Scholar]
  15. Dunbar J. C., Ergene E., Barraco R. A. Neuropeptide-Y stimulation of insulin secretion is mediated via the nucleus tractus solitarius. Horm Metab Res. 1992 Mar;24(3):103–105. doi: 10.1055/s-2007-1003268. [DOI] [PubMed] [Google Scholar]
  16. Ehrlich P., Tucker D., Asa S. L., Brubaker P. L., Drucker D. J. Inhibition of pancreatic proglucagon gene expression in mice bearing subcutaneous endocrine tumors. Am J Physiol. 1994 Nov;267(5 Pt 1):E662–E671. doi: 10.1152/ajpendo.1994.267.5.E662. [DOI] [PubMed] [Google Scholar]
  17. Frankish H. M., Dryden S., Hopkins D., Wang Q., Williams G. Neuropeptide Y, the hypothalamus, and diabetes: insights into the central control of metabolism. Peptides. 1995;16(4):757–771. doi: 10.1016/0196-9781(94)00200-p. [DOI] [PubMed] [Google Scholar]
  18. Geary N., Le Sauter J., Noh U. Glucagon acts in the liver to control spontaneous meal size in rats. Am J Physiol. 1993 Jan;264(1 Pt 2):R116–R122. doi: 10.1152/ajpregu.1993.264.1.R116. [DOI] [PubMed] [Google Scholar]
  19. Geary N. Pancreatic glucagon signals postprandial satiety. Neurosci Biobehav Rev. 1990 Fall;14(3):323–338. doi: 10.1016/s0149-7634(05)80042-9. [DOI] [PubMed] [Google Scholar]
  20. Halaas J. L., Gajiwala K. S., Maffei M., Cohen S. L., Chait B. T., Rabinowitz D., Lallone R. L., Burley S. K., Friedman J. M. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995 Jul 28;269(5223):543–546. doi: 10.1126/science.7624777. [DOI] [PubMed] [Google Scholar]
  21. Holst J. J. Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin. Biochem J. 1982 Dec 1;207(3):381–388. doi: 10.1042/bj2070381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Illig K. A., Maronian N., Peacock J. L. Cancer cachexia is transmissible in plasma. J Surg Res. 1992 Apr;52(4):353–358. doi: 10.1016/0022-4804(92)90115-g. [DOI] [PubMed] [Google Scholar]
  23. Kajimura N., Iseki H., Tanaka R., Ohue C., Otsubo K., Gyoutoku M., Sasaki K., Akiyama Y., Yamaguchi K. Toxohormones responsible for cancer cachexia syndrome in nude mice bearing human cancer cell lines. Cancer Chemother Pharmacol. 1996;38 (Suppl):S48–S52. doi: 10.1007/s002800051038. [DOI] [PubMed] [Google Scholar]
  24. Kalra S. P., Dube M. G., Sahu A., Phelps C. P., Kalra P. S. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10931–10935. doi: 10.1073/pnas.88.23.10931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kieffer T. J., McIntosh C. H., Pederson R. A. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology. 1995 Aug;136(8):3585–3596. doi: 10.1210/endo.136.8.7628397. [DOI] [PubMed] [Google Scholar]
  26. Larhammar D., Ericsson A., Persson H. Structure and expression of the rat neuropeptide Y gene. Proc Natl Acad Sci U S A. 1987 Apr;84(7):2068–2072. doi: 10.1073/pnas.84.7.2068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Larsen P. J., Jessop D. S., Chowdrey H. S., Lightman S. L., Mikkelsen J. D. Chronic administration of glucocorticoids directly upregulates prepro-neuropeptide Y and Y1-receptor mRNA levels in the arcuate nucleus of the rat. J Neuroendocrinol. 1994 Apr;6(2):153–159. doi: 10.1111/j.1365-2826.1994.tb00566.x. [DOI] [PubMed] [Google Scholar]
  28. Larsen P. J., Mikkelsen J. D., Jessop D. S., Lightman S. L., Chowdrey H. S. Neuropeptide Y mRNA and immunoreactivity in hypothalamic neuroendocrine neurons: effects of adrenalectomy and chronic osmotic stimulation. J Neurosci. 1993 Mar;13(3):1138–1147. doi: 10.1523/JNEUROSCI.13-03-01138.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Le Sauter J., Noh U., Geary N. Hepatic portal infusion of glucagon antibodies increases spontaneous meal size in rats. Am J Physiol. 1991 Jul;261(1 Pt 2):R162–R165. doi: 10.1152/ajpregu.1991.261.1.R162. [DOI] [PubMed] [Google Scholar]
  30. Lee G. H., Proenca R., Montez J. M., Carroll K. M., Darvishzadeh J. G., Lee J. I., Friedman J. M. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 1996 Feb 15;379(6566):632–635. doi: 10.1038/379632a0. [DOI] [PubMed] [Google Scholar]
  31. Madsen O. D., Andersen L. C., Michelsen B., Owerbach D., Larsson L. I., Lernmark A., Steiner D. F. Tissue-specific expression of transfected human insulin genes in pluripotent clonal rat insulinoma lines induced during passage in vivo. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6652–6656. doi: 10.1073/pnas.85.18.6652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Madsen O. D., Karlsen C., Blume N., Jensen H. I., Larsson L. I., Holst J. J. Transplantable glucagonomas derived from pluripotent rat islet tumor tissue cause severe anorexia and adipsia. Scand J Clin Lab Invest Suppl. 1995;220:27–35. [PubMed] [Google Scholar]
  33. Madsen O. D., Karlsen C., Nielsen E., Lund K., Kofod H., Welinder B., Rehfeld J. F., Larsson L. I., Steiner D. F., Holst J. J. The dissociation of tumor-induced weight loss from hypoglycemia in a transplantable pluripotent rat islet tumor results in the segregation of stable alpha- and beta-cell tumor phenotypes. Endocrinology. 1993 Nov;133(5):2022–2030. doi: 10.1210/endo.133.5.8404649. [DOI] [PubMed] [Google Scholar]
  34. Madsen O. D., Larsson L. I., Rehfeld J. F., Schwartz T. W., Lernmark A., Labrecque A. D., Steiner D. F. Cloned cell lines from a transplantable islet cell tumor are heterogeneous and express cholecystokinin in addition to islet hormones. J Cell Biol. 1986 Nov;103(5):2025–2034. doi: 10.1083/jcb.103.5.2025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. McCarthy H. D., McKibbin P. E., Perkins A. V., Linton E. A., Williams G. Alterations in hypothalamic NPY and CRF in anorexic tumor-bearing rats. Am J Physiol. 1993 Apr;264(4 Pt 1):E638–E643. doi: 10.1152/ajpendo.1993.264.4.E638. [DOI] [PubMed] [Google Scholar]
  36. McDevitt T. M., Todorov P. T., Beck S. A., Khan S. H., Tisdale M. J. Purification and characterization of a lipid-mobilizing factor associated with cachexia-inducing tumors in mice and humans. Cancer Res. 1995 Apr 1;55(7):1458–1463. [PubMed] [Google Scholar]
  37. McKibbin P. E., Cotton S. J., McCarthy H. D., Williams G. The effect of dexamethasone on neuropeptide Y concentrations in specific hypothalamic regions. Life Sci. 1992;51(16):1301–1307. doi: 10.1016/0024-3205(92)90020-p. [DOI] [PubMed] [Google Scholar]
  38. Minth C. D., Andrews P. C., Dixon J. E. Characterization, sequence, and expression of the cloned human neuropeptide Y gene. J Biol Chem. 1986 Sep 15;261(26):11974–11979. [PubMed] [Google Scholar]
  39. Mordes J. P., Rossini A. A. Tumor-induced anorexia in the Wistar rat. Science. 1981 Jul 31;213(4507):565–567. doi: 10.1126/science.6941477. [DOI] [PubMed] [Google Scholar]
  40. Morgan D. G., Lambert P. D., Smith D. M., Wilding J. P., Bloom S. R. Reduced NPY induced feeding in diabetic but not steroid-treated rats: lack of evidence for changes in receptor number or affinity. J Neuroendocrinol. 1996 Apr;8(4):283–290. doi: 10.1046/j.1365-2826.1996.04565.x. [DOI] [PubMed] [Google Scholar]
  41. Morley J. E. Neuropeptide regulation of appetite and weight. Endocr Rev. 1987 Aug;8(3):256–287. doi: 10.1210/edrv-8-3-256. [DOI] [PubMed] [Google Scholar]
  42. Murakami T., Shima K. Cloning of rat obese cDNA and its expression in obese rats. Biochem Biophys Res Commun. 1995 Apr 26;209(3):944–952. doi: 10.1006/bbrc.1995.1589. [DOI] [PubMed] [Google Scholar]
  43. Nelson K. A., Walsh D., Sheehan F. A. The cancer anorexia-cachexia syndrome. J Clin Oncol. 1994 Jan;12(1):213–225. doi: 10.1200/JCO.1994.12.1.213. [DOI] [PubMed] [Google Scholar]
  44. Nishimura E., Abrahamsen N., Hansen L. H., Lundgren K., Madsen O. Regulation of glucagon receptor expression. Acta Physiol Scand. 1996 Jul;157(3):329–332. doi: 10.1046/j.1365-201X.1996.35258000.x. [DOI] [PubMed] [Google Scholar]
  45. Norton J. A., Moley J. F., Green M. V., Carson R. E., Morrison S. D. Parabiotic transfer of cancer anorexia/cachexia in male rats. Cancer Res. 1985 Nov;45(11 Pt 1):5547–5552. [PubMed] [Google Scholar]
  46. O'Shea D., Gunn I., Chen X., Bloom S., Herbert J. A role for central glucagon-like peptide-1 in temperature regulation. Neuroreport. 1996 Feb 29;7(3):830–832. doi: 10.1097/00001756-199602290-00035. [DOI] [PubMed] [Google Scholar]
  47. Oliff A., Defeo-Jones D., Boyer M., Martinez D., Kiefer D., Vuocolo G., Wolfe A., Socher S. H. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell. 1987 Aug 14;50(4):555–563. doi: 10.1016/0092-8674(87)90028-6. [DOI] [PubMed] [Google Scholar]
  48. Orskov C., Jeppesen J., Madsbad S., Holst J. J. Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. J Clin Invest. 1991 Feb;87(2):415–423. doi: 10.1172/JCI115012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Orskov C., Poulsen S. S., Møller M., Holst J. J. Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I. Diabetes. 1996 Jun;45(6):832–835. doi: 10.2337/diab.45.6.832. [DOI] [PubMed] [Google Scholar]
  50. Paez X., Myers R. D. Insatiable feeding evoked in rats by recurrent perfusion of neuropeptide Y in the hypothalamus. Peptides. 1991 May-Jun;12(3):609–616. doi: 10.1016/0196-9781(91)90109-3. [DOI] [PubMed] [Google Scholar]
  51. Pelleymounter M. A., Cullen M. J., Baker M. B., Hecht R., Winters D., Boone T., Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995 Jul 28;269(5223):540–543. doi: 10.1126/science.7624776. [DOI] [PubMed] [Google Scholar]
  52. Pesonen U., Huupponen R., Rouru J., Koulu M. Hypothalamic neuropeptide expression after food restriction in Zucker rats: evidence of persistent neuropeptide Y gene activation. Brain Res Mol Brain Res. 1992 Dec;16(3-4):255–260. doi: 10.1016/0169-328x(92)90233-2. [DOI] [PubMed] [Google Scholar]
  53. Roscoe A. K., Myers R. D. Hypothermia and feeding induced simultaneously in rats by perfusion of neuropeptide Y in preoptic area. Pharmacol Biochem Behav. 1991 Aug;39(4):1003–1009. doi: 10.1016/0091-3057(91)90066-b. [DOI] [PubMed] [Google Scholar]
  54. Sahu A., Sninsky C. A., Phelps C. P., Dube M. G., Kalra P. S., Kalra S. P. Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats. Endocrinology. 1992 Dec;131(6):2979–2985. doi: 10.1210/endo.131.6.1446635. [DOI] [PubMed] [Google Scholar]
  55. Sanacora G., Kershaw M., Finkelstein J. A., White J. D. Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology. 1990 Aug;127(2):730–737. doi: 10.1210/endo-127-2-730. [DOI] [PubMed] [Google Scholar]
  56. Schwartz M. W., Baskin D. G., Bukowski T. R., Kuijper J. L., Foster D., Lasser G., Prunkard D. E., Porte D., Jr, Woods S. C., Seeley R. J. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes. 1996 Apr;45(4):531–535. doi: 10.2337/diab.45.4.531. [DOI] [PubMed] [Google Scholar]
  57. Schwartz M. W., Marks J. L., Sipols A. J., Baskin D. G., Woods S. C., Kahn S. E., Porte D., Jr Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology. 1991 May;128(5):2645–2647. doi: 10.1210/endo-128-5-2645. [DOI] [PubMed] [Google Scholar]
  58. Simons J. P., Schols A. M., Campfield L. A., Wouters E. F., Saris W. H. Plasma concentration of total leptin and human lung-cancer-associated cachexia. Clin Sci (Lond) 1997 Sep;93(3):273–277. doi: 10.1042/cs0930273. [DOI] [PubMed] [Google Scholar]
  59. Stanley B. G., Kyrkouli S. E., Lampert S., Leibowitz S. F. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides. 1986 Nov-Dec;7(6):1189–1192. doi: 10.1016/0196-9781(86)90149-x. [DOI] [PubMed] [Google Scholar]
  60. Stephens T. W., Basinski M., Bristow P. K., Bue-Valleskey J. M., Burgett S. G., Craft L., Hale J., Hoffmann J., Hsiung H. M., Kriauciunas A. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 1995 Oct 12;377(6549):530–532. doi: 10.1038/377530a0. [DOI] [PubMed] [Google Scholar]
  61. Strubbe J. H., Mein C. G. Increased feeding in response to bilateral injection of insulin antibodies in the VMH. Physiol Behav. 1977 Aug;19(2):309–313. doi: 10.1016/0031-9384(77)90343-2. [DOI] [PubMed] [Google Scholar]
  62. Tang-Christensen M., Larsen P. J., Göke R., Fink-Jensen A., Jessop D. S., Møller M., Sheikh S. P. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol. 1996 Oct;271(4 Pt 2):R848–R856. doi: 10.1152/ajpregu.1996.271.4.R848. [DOI] [PubMed] [Google Scholar]
  63. Tisdale M. J. Cancer cachexia. Anticancer Drugs. 1993 Apr;4(2):115–125. doi: 10.1097/00001813-199304000-00001. [DOI] [PubMed] [Google Scholar]
  64. Turton M. D., O'Shea D., Gunn I., Beak S. A., Edwards C. M., Meeran K., Choi S. J., Taylor G. M., Heath M. M., Lambert P. D. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature. 1996 Jan 4;379(6560):69–72. doi: 10.1038/379069a0. [DOI] [PubMed] [Google Scholar]
  65. Vettor R., Zarjevski N., Cusin I., Rohner-Jeanrenaud F., Jeanrenaud B. Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia. 1994 Dec;37(12):1202–1208. doi: 10.1007/BF00399793. [DOI] [PubMed] [Google Scholar]
  66. White J. D. Neuropeptide Y: a central regulator of energy homeostasis. Regul Pept. 1993 Dec 10;49(2):93–107. doi: 10.1016/0167-0115(93)90431-7. [DOI] [PubMed] [Google Scholar]
  67. White J. D., Olchovsky D., Kershaw M., Berelowitz M. Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats. Endocrinology. 1990 Feb;126(2):765–772. doi: 10.1210/endo-126-2-765. [DOI] [PubMed] [Google Scholar]
  68. Wilding J. P., Gilbey S. G., Bailey C. J., Batt R. A., Williams G., Ghatei M. A., Bloom S. R. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology. 1993 May;132(5):1939–1944. doi: 10.1210/endo.132.5.7682936. [DOI] [PubMed] [Google Scholar]
  69. Williams G., Gill J. S., Lee Y. C., Cardoso H. M., Okpere B. E., Bloom S. R. Increased neuropeptide Y concentrations in specific hypothalamic regions of streptozocin-induced diabetic rats. Diabetes. 1989 Mar;38(3):321–327. doi: 10.2337/diab.38.3.321. [DOI] [PubMed] [Google Scholar]
  70. Williams G., Steel J. H., Cardoso H., Ghatei M. A., Lee Y. C., Gill J. S., Burrin J. M., Polak J. M., Bloom S. R. Increased hypothalamic neuropeptide Y concentrations in diabetic rat. Diabetes. 1988 Jun;37(6):763–772. doi: 10.2337/diab.37.6.763. [DOI] [PubMed] [Google Scholar]
  71. Woods S. C., Lotter E. C., McKay L. D., Porte D., Jr Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature. 1979 Nov 29;282(5738):503–505. doi: 10.1038/282503a0. [DOI] [PubMed] [Google Scholar]
  72. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J. M. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994 Dec 1;372(6505):425–432. doi: 10.1038/372425a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES